Early Experience of High‑Dose‑Rate Interstitial Brachytherapy for Prostate Cancer in Nigeria
Before now, brachytherapy in public hospitals in Nigeria has focused almost exclusively on treating gynecological tumors, especially cervical cancer. Three years ago, the Federal Government procured brachytherapy equipment for six hospitals in Nigeria, including the University College Hospital, Ibadan. In this article, we present our experience as Nigerian pioneers using high‑dose‑rate brachytherapy modality for prostate cancer treatment, including challenges (being) encountered and recommendations for other centers planning to start this service in the country and beyond.
Authors
- Atara Ntekim (ORCID: https://orcid.org/0000-0003-4830-8365)
- A Adenipekun (ORCID: https://orcid.org/0000-0001-5856-1749)
- Sharif Adeniyi Folorunso (ORCID: https://orcid.org/0000-0003-3339-0378)
- Olusola Idowu (ORCID: https://orcid.org/0000-0002-2945-2268)
- Mutiu Alani Jimoh
- Folasire Ayorinde
- Foluke Oladele Sarimiye
- Bidemi I. Akinlade
- Adebayo Afolabi Oladeji
- Babatunde Olutoye Ogunnorin
- Abbas Adesina Abdus‑Salam
- Emmanuel Oyeyemi Oyekunle
- Augustine O. Takure
- Adeniyi Adedayo Olabu muyi
Institutions
- University College Hospital, Ibadan (NG)
Publication Details
- Published
- 2026-02-05
- DOI
- https://doi.org/10.82339/jrmt.vol4no1.36
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00